🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

549 results for “Hong” Clear

  1. LNG-IUS

    Hospital Authority, Hong Kong

    Endometriosis

    approved small molecule completed

    1 trial

  2. Levofloxacin

    Hospital Authority, Hong Kong

    Urinary Tract Infection

    approved small molecule active

    1 trial

  3. Lucentis

    Hospital Authority, Hong Kong

    Wet Macular Degeneration

    approved small molecule completed

    1 trial

  4. Methotrexate plus sulfasalazine

    Hospital Authority, Hong Kong

    Rheumatoid Arthritis

    approved small molecule terminated

    1 trial

  5. Metronidazole

    Hospital Authority, Hong Kong

    Helicobacter Pylori Infection

    approved small molecule completed

    1 trial

  6. MgSO4 plus Ropivacaine

    Hospital Authority, Hong Kong

    Efficacy and Safety of MgSO4 as Adjuvant to Scalp Block

    approved small molecule completed

    1 trial

  7. Minoxidil lotion 1%

    Hospital Authority, Hong Kong

    Eyebrow Hypotrichosis

    approved small molecule completed

    1 trial

  8. Minoxidil lotion 2%

    Hospital Authority, Hong Kong

    Hypotrichosis of Eyebrows

    approved small molecule completed

    1 trial

  9. Moxonidine 0.2 MG

    Hospital Authority, Hong Kong

    Central Sympathetic Nervous System Diseases

    approved small molecule completed

    1 trial

  10. Oral hygiene intervention

    The University of Hong Kong

    Acute Stroke

    approved other completed

    1 trial

  11. Oral prednisolone (30mg/day) for 28 days

    Hospital Authority, Hong Kong

    Esophageal Neoplasms

    approved small molecule active

    1 trial

  12. Oxycodone

    Hospital Authority, Hong Kong

    Postcraniotomy Pain

    approved small molecule completed

    1 trial

  13. Paliperidone ER

    Hospital Authority, Hong Kong

    Schizophrenia

    approved small molecule completed

    1 trial

  14. Paracetamol

    The University of Hong Kong

    Influenza

    approved small molecule completed

    1 trial

  15. Pegyinterferon-alfa-2a

    Chinese University of Hong Kong

    Chronic Hepaititis B

    approved small molecule completed

    1 trial

  16. Provase

    Chongqing Precision Biotech Co., Ltd

    Pruritus

    approved other completed

    1 trial

  17. Remifentanil

    Hospital Authority, Hong Kong

    Labor Pain

    approved small molecule active

    1 trial

  18. Renin-angiotensin system blockers

    Hospital Authority, Hong Kong

    Diabetes

    approved small molecule active

    1 trial

  19. Rifaximin Oral Tablet

    Hospital Authority, Hong Kong

    Irritable Bowel Syndrome With Diarrhea

    approved small molecule completed

    1 trial

  20. Rivaroxaban 2.5 MG Oral Tablet [Xarelto]

    The University of Hong Kong

    Atherosclerosis, Coronary

    approved small molecule completed

    1 trial

  21. Rosuvastatin

    Hospital Authority, Hong Kong

    Systemic Lupus Erythematosus

    approved small molecule active

    1 trial

  22. SGLT2 inhibitor (Empagliflozin 25 MG)

    Hospital Authority, Hong Kong

    Type2 Diabetes

    approved small molecule active

    1 trial

  23. SYSTANE™ Hydration Lubricant Eye Drops

    Hospital Authority, Hong Kong

    Dry Eye Syndromes

    approved small molecule active

    1 trial

  24. Salkera Emollient Foam

    Chongqing Precision Biotech Co., Ltd

    Keratosis Pilaris

    approved small molecule terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources